[Federal Register Volume 81, Number 1 (Monday, January 4, 2016)]
[Notices]
[Pages 101-102]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-33025]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 50-609; NRC-2013-0235]
Northwest Medical Isotopes, LLC
AGENCY: Nuclear Regulatory Commission.
ACTION: Construction permit application; docketing.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has determined
that the second and final part of the application for a construction
permit, submitted by Northwest Medical Isotopes, LLC (NWMI) is
acceptable for docketing. NWMI proposes to build a medical radioisotope
production facility located in Columbia, Missouri.
ADDRESSES: Please refer to Docket ID NRC-2013-0235 when contacting the
NRC about the availability of information regarding this document. You
may obtain publicly-available information related to this document
using any of the following methods:
Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2013-0235. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: [email protected]. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to [email protected]. The
ADAMS accession number for each document referenced in this document
(if that document is available in ADAMS) is provided the first time
that a document is referenced.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear
Reactor Regulation, telephone: 301-415-2856; email:
[email protected]; U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001.
[[Page 102]]
SUPPLEMENTARY INFORMATION: By letter dated July 20, 2015 (ADAMS
Accession No. ML15210A114), NWMI filed with the NRC, pursuant to
Section 103 of the Atomic Energy Act of 1954, as amended (AEA), and
part 50 of title 10 of the Code of Federal Regulations (10 CFR),
``Domestic Licensing of Production and Utilization Facilities,'' the
second and final part of its two-part application for a construction
permit for a medical radioisotope production facility. If granted, the
construction permit would allow NWMI to construct a production facility
in Columbia, Missouri. On June 8, 2015, the NRC published in the
Federal Register its acceptance of part one of NWMI's application for a
construction permit (80 FR 32418).
The NRC has completed its acceptance review of part two of NWMI's
application for a construction permit for a production facility as
defined in 10 CFR 50.2, ``Definitions.'' The NRC has determined that
part two was submitted in accordance with the requirements of 10 CFR
2.101(a)(5), completes the information required by 10 CFR 50.34(a), and
is acceptable for docketing. NWMI's construction permit application, in
its entirety, has been placed under Docket No. 50-609. Please reference
this docket number in all future correspondence.
The NRC expects that NWMI will submit an application for
fabricating low enriched uranium targets under 10 CFR part 70,
``Domestic Licensing of Special Nuclear Materials,'' as stated in
paragraph six (page 2) of NWMI's letter dated July 20, 2015.
The NRC's staff has started a review of the NWMI construction
permit application. The NRC's staff will provide NWMI with a schedule
that identifies significant milestones and the expected review
completion date. The schedule will include provisions for the NRC to
request additional information, if necessary.
A copy of the construction permit application will be referred to
the Advisory Committee on Reactor Safeguards for a review and report
consistent with 10 CFR 50.58, ``Hearings and report of the Advisory
Committee on Reactor Safeguards.''
In support of the review of the NWMI construction permit
application, a hearing will be conducted by the Commission or a Board
designated by the Chief of the Atomic Safety and Licensing Board Panel
in accordance with procedures in 10 CFR part 2, ``Agency Rules of
Practice and Procedure.'' A future Federal Register notice (FRN) will
announce the opportunity to petition for leave to intervene in a
hearing on the application as well as the time and place of the
hearing.
Additionally, in accordance with 10 CFR part 51, ``Environmental
Protection Regulations for Domestic Licensing and Related Regulatory
Functions,'' the NRC will also prepare an environmental impact
statement for the proposed action. The environmental impact statement
will evaluate the environmental impacts for construction, operation and
decommissioning of NWMI's radioisotope production facility. This review
will cover all activities at NWMI's radioisotope production facility,
including those under 10 CFR parts 50 and 70.
The docketing of the application does not predict whether the NRC
will grant or deny the requested construction permit. If the NRC finds
that NWMI's construction permit application meets the applicable
standards of the AEA and the NRC's regulations, and that required
notifications to other agencies and bodies have been made, the NRC will
issue a construction permit for a production facility under 10 CFR part
50, in the form and containing conditions and limitations that the NRC
finds appropriate and necessary.
This notice only addresses the start of a review to determine
whether the NRC will issue a construction permit for the proposed NWMI
facility. In order to operate and produce radioisotopes in its
facility, a separate application must be submitted by NWMI for the
NRC's review and approval, and, if docketed, would be the subject of a
separate FRN.
Dated at Rockville, Maryland, this 24 day of December, 2015.
For the Nuclear Regulatory Commission.
Michael F. Balazik,
Chief (Acting), Research and Test Reactors Licensing Branch, Division
of Policy and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2015-33025 Filed 12-31-15; 8:45 am]
BILLING CODE 7590-01-P